For years, aesthetic medicine was about intervention: fill what had hollowed, freeze what had moved, tighten what had sagged. As Dr Jaishree Sharad, cosmetic dermatologist and founder of Skinfiniti Aesthetic Skin & Laser Clinic, Mumbai, puts it, the traditional approach has largely been symptom-based: pores get microneedling, lines and wrinkles get Botox, hollows get fillers and sagging gets HIFU or RF. Now there’s a new idea in town—what if, instead of adding more to the face, we could get the skin to make more of its own? Enter regenerative beauty.
The term is suddenly everywhere, from Sculptra and PRP to PDRN and exosomes. The treatments aren’t interchangeable, and “regenerative” isn’t a formal stamp of approval. But they share a basic premise: stimulating the skin’s own repair and remodelling processes rather than simply changing what it looks like.
The timing is interesting. As the obviously overfilled face loses some of its appeal, subtlety is having a serious beauty moment. “People want to look natural,” says Dr Sharad. “They want to look like better versions of themselves.”
Don’t add. Stimulate
Sculptra is perhaps the clearest example of the shift. The poly-L-lactic acid injectable stimulates fibroblasts, the cells responsible for producing collagen, so the result builds gradually rather than appearing instantly like conventional filler. “So then over the next six weeks to three months there is new collagen regeneration,” explains Dr Sharad.
And this is where Sculptra gets easily confused with filler. Sculptra comes as a powder that is reconstituted before being injected into the deeper layers of the skin. Rather than physically filling a hollow, it stimulates collagen production at specific points, so the change unfolds over time. “In a filler, you’ll see a result immediately,” says Dr Sharad. “With Sculptra, it’ll take about two or three months, because it is making your own body produce its own collagen.”
That puts Sculptra in the growing category of biostimulators—treatments designed to trigger the body’s own collagen-building response. Calcium hydroxylapatite (CaHA), PRP, and some energy-based treatments sit in the broader conversation too. A systematic review published in Aesthetic Plastic Surgery in 2026 found improvements in elasticity, wrinkles, and facial volume with PLLA and CaHA biostimulators, though it noted the need for more standardised research.
For Dr Sharad, the appeal goes beyond collagen. “The idea is to gradually improve the quality of the skin rather than just adding volume,” she says. It’s less “what can you put in my face?” and more “what can my skin do for itself?”.
But the regenerative promise isn’t quite the same as prevention. “Nothing is preventative,” says Dr Sharad. Nor is it simply about treating visible signs of ageing. Instead, it can refer to treatments that stimulate collagen, influence inflammation, support tissue repair or affect cellular signalling.
That distinction matters. Regenerative doesn’t mean your skin is literally growing back from scratch. Many of these treatments work by modulating inflammation and signalling the body’s own repair pathways. “They are not directly rebuilding cartilage, collagen, fat,” says Dr Sharad. “They are not biologic fillers.”
And patience is part of the deal. “Whatever you do in terms of regenerative medicine, it’s going to take three to four months to show results,” says Dr Sharad. “It’s not overnight, it’s not some miracle.”
Then salmon DNA went viral
PDRN and polynucleotides took regenerative aesthetics from the clinic to the beauty algorithm, with the internet inevitably turning them into “salmon DNA” or “salmon sperm” facials. Yet the science is less clickbait-y. “Very simply, PDRN and polynucleotides are DNA-derived materials,” says Dr Geoffrey Vaz, MD, dermatologist and founder of Maven Esthetics. PDRN consists of shorter DNA fragments, while polynucleotides generally refer to longer chains. Both are being studied for roles in cellular repair, inflammation modulation, and processes involved in tissue regeneration.
The evidence is promising but still developing. Vaz stresses that the strength of evidence isn’t the same across PDRN, polynucleotides, and exosomes. For polynucleotides, he points to clinical studies showing improvements in skin texture, elasticity, and wrinkles, but notes that a recent systematic review included only nine studies involving 219 patients, with the overall evidence quality ranging from low to moderate. “We still need larger, better-designed studies,” he says.
Even on Indian beauty Reddit, recent threads have questioned whether PDRN is genuinely worth the price, whether vegan PDRN delivers lasting results, and whether some of the current hype amounts to little more than temporary hydration and plumping. The ingredient might have gone mainstream, but the verdict is still out.
Exosomes are where it gets murky
Think of exosomes as tiny messengers released by cells. “They can carry proteins, lipids, and nucleic acids that influence the behaviour of other cells,” explains Vaz. In dermatology, the interest is around whether those signals can support processes such as collagen production, wound healing, and skin repair.
Multiple reviews have reported promising results for areas including wrinkles, elasticity, hydration, and pigmentation. But studies vary widely in their formulations, sources, protocols, and delivery methods. And that’s the catch. “Regenerative” doesn’t tell you what’s actually in the vial. Vaz points to differences in sourcing, preparation, and delivery as reasons not to treat every exosome product as equivalent. Dr Sharad is more blunt: “Nothing is regulated. So again, it’s a big question mark.”
She also points out that exosomes aren’t one uniform thing: they can be derived from different cellular sources, including bone marrow, blood, fat or umbilical-cord-derived material, raising questions around sourcing, purification, manufacturing, and safety. Plant-derived exosome products are also entering the conversation, but she notes that these too are not yet standardised.
Now your serum wants in
The regenerative boom was never going to stay inside the clinic. PDRN is already having a moment in serums, masks, and ampoules, while exosome-based formulas are making their way onto skincare shelves. But what goes into a syringe doesn’t automatically translate to a bottle. “The ingredients may be similar, but the delivery is fundamentally different,” says Vaz. An injectable delivers the material directly into the skin at a controlled depth and concentration; a topical still has the skin barrier to get through.
So, if your serum is promising injectable-level regeneration, perhaps keep the credit card—and the expectations—firmly in check.
Beyond anti-ageing
Maybe the reason regenerative beauty feels so current is because we’re getting tired of the anti-ageing arms race. The new aspiration isn’t necessarily to look 10 years younger. It’s to have skin that looks healthy, resilient, and is good at its job. That fits neatly with the wider longevity conversation, where the focus is shifting from simply living longer to maintaining function for longer.
And regenerative aesthetics aren’t entirely new. RF, HIFU, and fractional lasers have long relied on controlled injury and repair to stimulate collagen remodelling. Dr Sharad describes these established energy-based treatments as the “workhorses” of collagen stimulation—a useful reminder that the regenerative conversation didn’t begin with the latest injectable or viral ingredient. The novelty isn’t necessarily the biology. It’s the packaging, language, and sheer volume of attention around it.
What’s changed is the ambition. “Anti-ageing” says fight what is happening to me. “Regenerative” says help my body do what it already knows how to do. It’s a much more seductive proposition. Of course, Sculptra, PRP, PDRN and exosomes aren’t four versions of the same treatment. Some have considerably more clinical evidence behind them than others. And “regenerative” isn’t a magic word that turns an experimental treatment into an established one. Vaz’s advice to consumers is refreshingly simple: ask what exactly is being used, what evidence supports it for your particular concern, and how it’s being delivered.
Because perhaps the most interesting thing about regenerative beauty isn’t that we’ve found a way to stop ageing. It’s that aesthetics may finally be moving on from “How can I change my face?” to “How can I make my skin work better?” And honestly, that’s a much more interesting beauty goal.
